tiprankstipranks
Aeterna Zentaris: Strong Cash Reserve Amidst Upcoming Merger
Company Announcements

Aeterna Zentaris: Strong Cash Reserve Amidst Upcoming Merger

Aeterna Zentaris Inc. (TSE:AEZS) has released an update.

Don't Miss Our Christmas Offers:

Aeterna Zentaris Inc. announced a strong cash position of $29.5 million at the end of the first quarter of 2024, despite a net loss of $5.8 million due to increased expenses, partially offset by decreased R&D costs. The company also completed recruitment for its DETECT-trial and is on schedule to finalize a merger with Ceapro Inc. by the second quarter of 2024.

For further insights into TSE:AEZS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskCOSCIENS Biopharma Debuts New Name and Ticker
TheFlyAeterna Zentaris announces name change to Cosciens Biopharma
TipRanks Auto-Generated NewsdeskAeterna Zentaris Release: A Technical Glitch?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App